Clinical trial risk in leukemia: Biomarkers and trial design.

Li, Alice J; Dhanraj, Jasper P; Lopes, Gilberto; Parker, Jayson L

Li, Alice J; Dhanraj, Jasper P; Lopes, Gilberto; Parker, Jayson L.

Afiliação

Li AJ; Institute for Management and Innovation, Master of Biotechnology Program, University of Toronto Mississauga, Mississauga, Ontario, Canada.
Dhanraj JP; Institute for Management and Innovation, Master of Biotechnology Program, University of Toronto Mississauga, Mississauga, Ontario, Canada.
Lopes G; Department of Medical Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA.
Parker JL; Institute for Management and Innovation, Master of Biotechnology Program, University of Toronto Mississauga, Mississauga, Ontario, Canada.

Hematol Oncol ; 39(1): 105-113, 2021 Feb.

Article em En | MEDLINE | ID: mdl-33078436

Assuntos

Antineoplásicos/uso terapêutico; Biomarcadores Tumorais/metabolismo; Aprovação de Drogas; Leucemia/tratamento farmacológico; Ensaios Clínicos como Assunto; Humanos; Leucemia/metabolismo; Fatores de Risco; Estados Unidos; United States Food and Drug Administration

Palavras-chave

acute lymphocytic leukemia; acute myeloid leukemia; biomarker; chronic lymphocytic leukemia; chronic myeloid leukemia; clinical trial risk; drug development; leukemia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia / Biomarcadores Tumorais / Aprovação de Drogas / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google